⌘K

Home/Filings/4/0001493152-23-021525

4//SEC Filing

Huntsman Ronald Kirk 4

Accession 0001493152-23-021525

CIK 0001716166other

View on SEC.gov Company Profile

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 7:15 PM ET

Size

5.5 KB

Accession

0001493152-23-021525

Insider Transaction Report

Form 4

Period: 2023-06-14

Vivos Therapeutics, Inc.VVOS

Huntsman Ronald Kirk

DirectorChief Executive Officer10% Owner

Transactions

Purchase
Common Stock
2023-06-14$0.49/sh+10,000$4,900→ 57,500 total

Holdings

Common Stock
(indirect: See footnote)
1,740,000

Footnotes (1)

[F1]Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Vivos Therapeutics, Inc.

CIK 0001716166

Entity typeother

Related Parties

1

filerCIK 0001835498

Filing Metadata

Form type: 4
Filed: Jun 14, 8:00 PM ET
Accepted: Jun 15, 7:15 PM ET
Size: 5.5 KB

View on SEC.gov